Passa al contenuto
Merck

SIKVAV-modified highly superporous PHEMA scaffolds with oriented pores for spinal cord injury repair.

Journal of tissue engineering and regenerative medicine (2013-02-13)
Šárka Kubinová, Daniel Horák, Aleš Hejčl, Zdeněk Plichta, Jiří Kotek, Vladimír Proks, Serhiy Forostyak, Eva Syková
ABSTRACT

The architecture and mechanical properties of a scaffold for spinal cord injury treatment must provide tissue integration as well as effective axonal regeneration. Previous work has demonstrated the cell-adhesive and growth-promoting properties of the SIKVAV (Ser-Ile-Lys-Val-Ala-Val)-modified highly superporous poly(2-hydroxethyl methacrylate) (PHEMA) hydrogels. The aim of the current study was to optimize the porosity and mechanical properties of this type of hydrogel in order to develop a suitable scaffold for the repair of spinal cord tissue. Three types of highly superporous PHEMA hydrogels with oriented pores of ~60 µm diameter, porosities of 57-68% and equivalent stiffness characterized by elasticity moduli in the range 3-45 kPa were implanted into a spinal cord hemisection, and their integration into the host tissue, as well as the extent of axonal ingrowth into the scaffold pores, were histologically evaluated. The best tissue response was found with a SIKVAV-modified PHEMA hydrogel with 68% porosity and a moderate modulus of elasticity (27 kPa in the direction along the pores and 3.6 kPa in the perpendicular direction). When implanted into a spinal cord transection, the hydrogel promoted tissue bridging as well as aligned axonal ingrowth. In conclusion, a prospective oriented scaffold architecture of SIKVAV-modified PHEMA hydrogels has been developed for spinal cord injury repair; however, to develop an effective treatment for spinal cord injury, multiple therapeutic approaches are needed.

MATERIALI
Numero di prodotto
Marchio
Descrizione del prodotto

Sigma-Aldrich
Triton X-100, laboratory grade
Sigma-Aldrich
1,1,1,3,3,3-esafluoro-2-propanolo, ≥99%
Sigma-Aldrich
DAPI, for nucleic acid staining
Sigma-Aldrich
Imidazolo, ReagentPlus®, 99%
Sigma-Aldrich
Imidazolo, ACS reagent, ≥99% (titration)
Sigma-Aldrich
2,2′-azobis(2-metilpropionitrile), 98%
Sigma-Aldrich
Imidazolo, Molecular Biology, ≥99% (titration)
Sigma-Aldrich
Imidazolo, BioUltra, ≥99.5% (GC)
Sigma-Aldrich
Imidazole buffer Solution, BioUltra, 1 M in H2O
Sigma-Aldrich
Imidazolo, puriss. p.a., ≥99.5% (GC)
Sigma-Aldrich
Acido fenilacetico, 99%
Sigma-Aldrich
Aldrithiol-2, 98%
Sigma-Aldrich
2,2′-Dithiodipyridine, powder
Sigma-Aldrich
Acido fenilacetico, ≥99%, FCC, FG
Sigma-Aldrich
Imidazolo, ≥99% (titration), crystalline
Sigma-Aldrich
Imidazolo, anhydrous, free-flowing, Redi-Dri, ACS reagent, ≥99%
Sigma-Aldrich
Imidazolo, BioUltra, Molecular Biology, ≥99.5% (GC)
Sigma-Aldrich
Imidazolo, ReagentPlus®, 99%, Redi-Dri, free-flowing
Sigma-Aldrich
Imidazolo, Molecular Biology, ≥99% (titration), free-flowing, Redi-Dri